La battaglia sul vaccino anti Covid per fermare la pandemia

A cura di
Condividi:

French President Emmanuel Macron adjusts his protective mask as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron looks down as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, center, Thomas Triomphe, right, Executive Vice President of Sanofi Pasteur, and Paul Hudson, Chief Executive Officer of Sanofi, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
A researcher works at an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
A researcher works at an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, wearing a protective face mask, listens to researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron adjusts his mask as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, wearing a protective face mask, listens to researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, center, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron talks with researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, center, Thomas Triomphe, right, Executive Vice President of Sanofi Pasteur, and Paul Hudson, Chief Executive Officer of Sanofi, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
From left to right, Board Director of Sanofi Serge Weinberg, CEO of Sanofi Paul Hudson, President of Sanofi France Olivier Bogillot French President Emmanuel Macron and arrive at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron adjusts his protective face mask as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
From left to right, Board Director of Sanofi Serge Weinberg, French President Emmanuel Macron, CEO of Sanofi Paul Hudson, and President of Sanofi France Olivier Bogillot arrive at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron adjusts his protective face mask as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020. The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (Gonzalo Fuentes/Pool via AP)
From left to right, Board Director of Sanofi Serge Weinberg, CEO of Sanofi Paul Hudson, French President Emmanuel Macron and President of Sanofi France Olivier Bogillot pose for a group photo at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron listens to researchers as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron talks to a group of esearchers as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)

Melle foto Ap, il presidente francese in visita nei laboratori della società Sanofi dopo la polemica contro il vertice della multinazionale farmaceutica che aveva annunciato di destinare l’eventuale risultato positivo delle loro ricerche agli Usa.

Il presidente Donald Trump ha, infatti, annunciato di aver lanciato l’operazione “Warp Speed”da 10 miliardi di dollari per arrivare prima degli altri contendenti a trovare l’antidoto al virus che ha messo in ginocchio vaste aree del pianeta.

Siamo davanti ad una nuova sfida geopolitica che richiede l’impegno per la salvaguardia dei beni comuni e l’accesso universale alle cure.

Commenta l'articolo

Guarda anche

Siti amici

Edicola Digitale Città Nuova - Reader Scarica l'app
CittaNuova.it
Simple Share Buttons